These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 23881285)
21. FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes. Tsuji M; Ueda S; Hirayama T; Okuda K; Sakaguchi Y; Isono A; Nagasawa H Org Biomol Chem; 2013 May; 11(18):3030-7. PubMed ID: 23532512 [TBL] [Abstract][Full Text] [Related]
22. Selective nonpeptidic fluorescent ligands for oxytocin receptor: design, synthesis, and application to time-resolved FRET binding assay. Karpenko IA; Margathe JF; Rodriguez T; Pflimlin E; Dupuis E; Hibert M; Durroux T; Bonnet D J Med Chem; 2015 Mar; 58(5):2547-52. PubMed ID: 25642985 [TBL] [Abstract][Full Text] [Related]
23. Novel probes showing specific fluorescence enhancement on binding to a hexahistidine tag. Kamoto M; Umezawa N; Kato N; Higuchi T Chemistry; 2008; 14(26):8004-12. PubMed ID: 18645992 [TBL] [Abstract][Full Text] [Related]
24. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands. Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743 [TBL] [Abstract][Full Text] [Related]
25. Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist. Schneider E; Keller M; Brennauer A; Hoefelschweiger BK; Gross D; Wolfbeis OS; Bernhardt G; Buschauer A Chembiochem; 2007 Nov; 8(16):1981-8. PubMed ID: 17876753 [TBL] [Abstract][Full Text] [Related]
26. [3H]HEMADO--a novel tritiated agonist selective for the human adenosine A3 receptor. Klotz KN; Falgner N; Kachler S; Lambertucci C; Vittori S; Volpini R; Cristalli G Eur J Pharmacol; 2007 Feb; 556(1-3):14-8. PubMed ID: 17126322 [TBL] [Abstract][Full Text] [Related]
27. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor. Volpini R; Dal Ben D; Lambertucci C; Taffi S; Vittori S; Klotz KN; Cristalli G J Med Chem; 2007 Mar; 50(6):1222-30. PubMed ID: 17309246 [TBL] [Abstract][Full Text] [Related]
28. Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A Yang X; van Veldhoven JPD; Offringa J; Kuiper BJ; Lenselink EB; Heitman LH; van der Es D; IJzerman AP J Med Chem; 2019 Apr; 62(7):3539-3552. PubMed ID: 30869893 [TBL] [Abstract][Full Text] [Related]
29. N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes. Gera L; Roy C; Bawolak MT; Charest-Morin X; Marceau F Peptides; 2012 Apr; 34(2):433-46. PubMed ID: 22349904 [TBL] [Abstract][Full Text] [Related]
30. Relaxin-3, INSL5, and their receptors. Liu C; Lovenberg TW Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022 [TBL] [Abstract][Full Text] [Related]
31. Selective two-step labeling of proteins with an off/on fluorescent probe. Hirabayashi K; Hanaoka K; Shimonishi M; Terai T; Komatsu T; Ueno T; Nagano T Chemistry; 2011 Dec; 17(52):14763-71. PubMed ID: 22106092 [TBL] [Abstract][Full Text] [Related]
32. 2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation. Squarcialupi L; Colotta V; Catarzi D; Varano F; Filacchioni G; Varani K; Corciulo C; Vincenzi F; Borea PA; Ghelardini C; Di Cesare Mannelli L; Ciancetta A; Moro S J Med Chem; 2013 Mar; 56(6):2256-69. PubMed ID: 23427825 [TBL] [Abstract][Full Text] [Related]
34. Discovery of a competitive apelin receptor (APJ) antagonist. Macaluso NJ; Pitkin SL; Maguire JJ; Davenport AP; Glen RC ChemMedChem; 2011 Jun; 6(6):1017-23. PubMed ID: 21560248 [TBL] [Abstract][Full Text] [Related]
35. Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A Comeo E; Trinh P; Nguyen AT; Nowell CJ; Kindon ND; Soave M; Stoddart LA; White JM; Hill SJ; Kellam B; Halls ML; May LT; Scammells PJ J Med Chem; 2021 May; 64(10):6670-6695. PubMed ID: 33724031 [TBL] [Abstract][Full Text] [Related]
36. Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H Kok ZY; Stoddart LA; Mistry SJ; Mocking TAM; Vischer HF; Leurs R; Hill SJ; Mistry SN; Kellam B J Med Chem; 2022 Jun; 65(12):8258-8288. PubMed ID: 35734860 [TBL] [Abstract][Full Text] [Related]
37. Quantum dot-based screening system for discovery of g protein-coupled receptor agonists. Lee J; Kwon YJ; Choi Y; Kim HC; Kim K; Kim J; Park S; Song R Chembiochem; 2012 Jul; 13(10):1503-8. PubMed ID: 22692979 [TBL] [Abstract][Full Text] [Related]
38. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, pharmacological characterization of a fluorescent agonist of the P2Y₁₄ receptor. Kiselev E; Balasubramanian R; Uliassi E; Brown KA; Trujillo K; Katritch V; Hammes E; Stevens RC; Harden TK; Jacobson KA Bioorg Med Chem Lett; 2015 Nov; 25(21):4733-4739. PubMed ID: 26303895 [TBL] [Abstract][Full Text] [Related]
40. Fragment screening at adenosine-A(3) receptors in living cells using a fluorescence-based binding assay. Stoddart LA; Vernall AJ; Denman JL; Briddon SJ; Kellam B; Hill SJ Chem Biol; 2012 Sep; 19(9):1105-15. PubMed ID: 22999879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]